184 related articles for article (PubMed ID: 33486145)
1. Management of Hypersensitivity Reactions to Nondextran Iron Products: New Insights Into Predisposing Risk Factors.
Steveling-Klein EH; Mateluna CM; Meienberg A; Hartmann K; Bircher A; Scherer Hofmeier K
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2406-2414.e2. PubMed ID: 33486145
[TBL] [Abstract][Full Text] [Related]
2. Comparison of hypersensitivity reactions of intravenous iron: iron isomaltoside-1000 (Monofer
Mulder MB; van den Hoek HL; Birnie E; van Tilburg AJP; Westerman EM
Br J Clin Pharmacol; 2019 Feb; 85(2):385-392. PubMed ID: 30393904
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017.
Ehlken B; Nathell L; Gohlke A; Bocuk D; Toussi M; Wohlfeil S
Drug Saf; 2019 Mar; 42(3):463-471. PubMed ID: 30535629
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the reported rates of hypersensitivity reactions associated with iron dextran and ferric carboxymaltose based on global data from VigiBase™ and IQVIA™ MIDAS® over a ten-year period from 2008 to 2017.
Durup D; Schaffalitzky de Muckadell P; Strom CC
Expert Rev Hematol; 2020 May; 13(5):557-564. PubMed ID: 32129113
[No Abstract] [Full Text] [Related]
5. Reported Severe Hypersensitivity Reactions after Intravenous Iron Administration in the European Economic Area (EEA) Before and After Implementation of Risk Minimization Measures.
Nathell L; Gohlke A; Wohlfeil S
Drug Saf; 2020 Jan; 43(1):35-43. PubMed ID: 31583644
[TBL] [Abstract][Full Text] [Related]
6. Drug Hypersensitivity Reactions Documented in Electronic Health Records within a Large Health System.
Wong A; Seger DL; Lai KH; Goss FR; Blumenthal KG; Zhou L
J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1253-1260.e3. PubMed ID: 30513361
[TBL] [Abstract][Full Text] [Related]
7. Finding the Optimal Alternative for Immediate Hypersensitivity to Low-Osmolar Iodinated Contrast.
Sohn KH; Seo JH; Kang DY; Lee SY; Kang HR
Invest Radiol; 2021 Aug; 56(8):480-485. PubMed ID: 33587497
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characterization and Diagnostic Approaches for Patients Reporting Hypersensitivity Reactions to Quinolones.
Doña I; Pérez-Sánchez N; Salas M; Barrionuevo E; Ruiz-San Francisco A; Hernández Fernández de Rojas D; Martí-Garrido J; Andreu-Ros I; López-Salgueiro R; Moreno E; Torres MJ
J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2707-2714.e2. PubMed ID: 32376487
[TBL] [Abstract][Full Text] [Related]
9. Approach to hypersensitivity reactions from intravenous iron preparations.
Morales Mateluna CA; Scherer Hofmeier K; Bircher AJ
Allergy; 2017 May; 72(5):827-830. PubMed ID: 27977865
[TBL] [Abstract][Full Text] [Related]
10. Indirect methods of comparison of the safety of ferric derisomaltose, iron sucrose and ferric carboxymaltose in the treatment of iron deficiency anemia.
Pollock RF; Biggar P
Expert Rev Hematol; 2020 Feb; 13(2):187-195. PubMed ID: 31928094
[No Abstract] [Full Text] [Related]
11. Clinical data for intravenous iron - debunking the hype around hypersensitivity.
Achebe M; DeLoughery TG
Transfusion; 2020 Jun; 60(6):1154-1159. PubMed ID: 32479668
[TBL] [Abstract][Full Text] [Related]
12. The diagnosis of hypersensitivity to antibiotics is rarely confirmed by allergy work-up in cystic fibrosis patients.
Braun C; Reix P; Durieu I; Nove-Josserand R; Durupt S; Ohlmann C; Mainguy C; Nicolas JF; Nosbaum A; Jubin V
Pediatr Allergy Immunol; 2020 May; 31(4):396-404. PubMed ID: 31880334
[TBL] [Abstract][Full Text] [Related]
13. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests.
Ponvert C; Perrin Y; Bados-Albiero A; Le Bourgeois M; Karila C; Delacourt C; Scheinmann P; De Blic J
Pediatr Allergy Immunol; 2011 Jun; 22(4):411-8. PubMed ID: 21535179
[TBL] [Abstract][Full Text] [Related]
14. Evaluation and management of hypersensitivity to proton pump inhibitors.
Bose S; Guyer A; Long A; Banerji A
Ann Allergy Asthma Immunol; 2013 Dec; 111(6):452-7. PubMed ID: 24267357
[TBL] [Abstract][Full Text] [Related]
15. Utility of Risk Stratification for Paclitaxel Hypersensitivity Reactions.
Otani IM; Lax T; Long AA; Slawski BR; Camargo CA; Banerji A
J Allergy Clin Immunol Pract; 2018; 6(4):1266-1273.e2. PubMed ID: 28986119
[TBL] [Abstract][Full Text] [Related]
16. Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions.
Bager P; Hvas CL; Dahlerup JF
Br J Clin Pharmacol; 2017 May; 83(5):1118-1125. PubMed ID: 27859495
[TBL] [Abstract][Full Text] [Related]
17. Vancomycin Hypersensitivity Reactions Documented in Electronic Health Records.
Alvarez-Arango S; Yerneni S; Tang O; Zhou L; Mancini CM; Blackley SV; Keet CA; Blumenthal KG
J Allergy Clin Immunol Pract; 2021 Feb; 9(2):906-912. PubMed ID: 33011300
[TBL] [Abstract][Full Text] [Related]
18. Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock).
Limsuwan T; Demoly P
Med Clin North Am; 2010 Jul; 94(4):691-710, x. PubMed ID: 20609858
[TBL] [Abstract][Full Text] [Related]
19. Role of Skin Tests in the Diagnosis of Immediate Hypersensitivity Reactions to Taxanes: Results of a Multicenter Study.
Pagani M; Bavbek S; Dursun AB; Bonadonna P; Caralli M; Cernadas J; Cortellini G; Costantino MT; Gelincik A; Lucchini G; Castells M
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):990-997. PubMed ID: 30292919
[TBL] [Abstract][Full Text] [Related]
20. Incidence and Risk of Oxaliplatin-Induced Hypersensitivity in Patients with Asymptomatic Prior Exposure: A Prospective Observational Study.
Sohn KH; Kang DY; Kim JY; Lee SY; Lee KH; Han SW; Kang HR
J Allergy Clin Immunol Pract; 2018; 6(5):1642-1648.e2. PubMed ID: 29454708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
